ClinicalTrials.gov record
Recruiting Phase 1 Interventional

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

ClinicalTrials.gov ID: NCT04637763

Public ClinicalTrials.gov record NCT04637763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Multicenter, Open-Label Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Patients With Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Study identification

NCT ID
NCT04637763
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Caribou Biosciences, Inc.
Industry
Enrollment
72 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2021
Primary completion
Jul 31, 2025
Completion
Aug 31, 2025
Last update posted
Mar 23, 2025

2021 – 2025

United States locations

U.S. sites
31
U.S. states
20
U.S. cities
31
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 Terminated
Banner MD Anderson Cancer Center Gilbert Arizona 85234 Recruiting
HonorHealth Scottsdale Arizona 85258 Recruiting
University of Arizona Cancer Center Tucson Arizona 85724 Recruiting
University of Arkansas Little Rock Arkansas 72205 Recruiting
University of California San Diego Moores Cancer Center La Jolla California 92073 Recruiting
University of Southern California, Norris Comprehensive Cancer Center Los Angeles California 90089 Recruiting
Chao Family Comprehensive Cancer Center/University of California Irvine Orange California 92868 Recruiting
Advent Health Orlando Florida 32803 Recruiting
Bone and Marrow Transplant Group of Georgia Atlanta Georgia 30342 Recruiting
Georgia Cancer Center at Augusta University Augusta Georgia 30912 Recruiting
Holden Comprehensive Cancer Center at the University of Iowa Iowa City Iowa 52242 Recruiting
University of Kentucky Markey Cancer Lexington Kentucky 40536 Recruiting
Norton Cancer Institute Louisville Kentucky 40207 Recruiting
Tufts Medical Center Boston Massachusetts 02111 Recruiting
Hackensack Medical Center Hackensack New Jersey 07601 Recruiting
Atlantic Health System Morristown New Jersey 07960 Recruiting
Nyu Langone Health New York New York 10016 Recruiting
Montefiore Medical Center The Bronx New York 10461 Recruiting
Oncology Hematology Care Cincinnati Ohio 45242 Recruiting
Ohio State University James Cancer Hospital Columbus Ohio 43210 Terminated
Oregon Health & Science University Portland Oregon 97239 Recruiting
University of Pennsylvania Philadelphia Pennsylvania 19104 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37323 Recruiting
Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 Recruiting
MD Anderson Cancer Center Houston Texas 77030-4009 Recruiting
Huntsman Cancer Institute at the University of Utah Salt Lake City Utah 84112 Recruiting
Virginia Oncology Associates Norfolk Virginia 23502 Recruiting
Virginia Commonwealth University (VCU) Richmond Virginia 23219 Recruiting
Swedish Cancer Institute Seattle Washington 98104 Terminated
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04637763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04637763 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →